晚期肾病患者腰椎融合术后的并发症与死亡率
基于PearlDiver数据库2005至2012年Medicare数据的回顾性数据库研究,比较1654例晚期肾病与242085例匹配对照行1至2节段后外侧腰椎融合术后的结局。晚期肾病组90天全因医疗并发症率21.3%对14.2%、感染率4.4%对1.8%、手术当日输血率20.7%对14.7%均更高;90天死亡率1.1%对0.2%、1年死亡率1.9%对0.7%也更高。
要点
- 晚期肾病组90天全因医疗并发症21.3%对14.2%,OR 1.64(95%CI 1.44-1.85,P<0.0001)。
- 晚期肾病组感染4.4%对1.8%(OR 2.43,95%CI 1.87-3.16,P<0.0001)。
- 晚期肾病组90天死亡率1.1%对0.2%(OR 5.05),1年死亡率1.9%对0.7%(OR 2.77)。
核心结论
- 晚期肾病老年患者行1至2节段后外侧腰椎融合术后3个月内发生重大医疗并发症的OR为1.6倍,1年死亡OR为2.8倍,均高于匹配对照。
研究设计与样本
- 回顾性数据库研究,查询PearlDiver数据库2005至2012年Medicare数据,纳入行初次1至2节段后外侧腰椎融合术的患者,分为晚期肾病组(N=1654)与对照组(N=242085),对照组按年龄、性别和合并症与肾病组匹配。
主要发现
- 肾病组全因医疗并发症21.3% vs 对照组14.2%(OR 1.64,95%CI 1.44-1.85,P<0.0001)。
- 肾病组感染4.4% vs 对照组1.8%(OR 2.43,95%CI 1.87-3.16,P<0.0001)。
- 肾病组手术当日输血20.7% vs 对照组14.7%(OR 1.51,95%CI 1.33-1.72,P<0.0001)。
- 肾病组90天死亡率1.1% vs 对照组0.2%(OR 5.05,95%CI 2.90-8.77,P<0.0001)。
- 肾病组1年死亡率1.9% vs 对照组0.7%(OR 2.77,95%CI 1.87-4.11,P<0.0001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Retrospective database review. OBJECTIVE: To assess complication and mortality rates after lumbar spinal fusion surgery in patients with late stage renal disease. SUMMARY OF BACKGROUND DATA: Lumbar spinal fusion surgeries are common in elderly patients who are well-known to have increased comorbidity burden. Elderly patients with severe chronic kidney disease (CKD) represent a population with poorly understood mortality and complication rates after spine surgery. METHODS: Medicare data from the PearlDiver Database (2005-2012) was queried for patients who underwent primary 1-2 level posterolateral lumbar spine fusion surgeries. This cohort was divided into two study groups: a cohort with a preexisting diagnosis of late stage renal disease (N = 1654) and a control cohort of all other patients (N = 242,085). The control group was matched to the renal disease cohort by age, sex, and comorbidities. Moreover, 90-day complication rates and 90-day and 1-year mortality were assessed. RESULTS: The renal disease cohort had increased rates of all medical complications (21.3 vs. 14.2%; odds ratio, OR, 1.64; 95% confidence intervals, CI, 1.44 -1.85; P < 0.0001). Increased rates of infection (4.4 vs. 1.8%; OR 2.43; 95% CI 1.87 - 3.16; P < 0.0001) and procedure-day blood transfusions (20.7 vs. 14.7%; OR 1.51; 95% CI 1.33 - 1.72; P < 0.0001) were also observed in the renal disease cohort. Both 90-day (1.1 vs. 0.2%; OR 5.05; 95% CI 2.90-8.77; P < 0.0001) and 1-year mortality (1.9 vs. 0.7%; OR 2.77; 95% CI 1.87-4.11; P < 0.0001) were significantly higher in the renal disease group compared with the control group. CONCLUSION: Elderly patients with late-stage renal disease treated with 1-2 level posterolateral lumbar fusion have 1.6 times increased odds of experiencing a major medical complication within 3 months of surgery and 2.8 times increased odds of 1-year mortality when compared with matched controls. LEVEL OF EVIDENCE: 3.
引用
- Puvanesarajah V, Jain A, Hess DE, et al. Complications and Mortality After Lumbar Spinal Fusion in Elderly Patients With Late Stage Renal Disease. Spine (Phila Pa 1976). 2016. PMID: 27054452. doi:10.1097/BRS.0000000000001618
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。